More on DNDN by Jack Haddad
Latest DNDN Transcript
-
Dendreon Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
Thu, May 17
Latest DNDN Articles
-
2 Pharmaceutical Companies Trading Below Net Cash
Mon, May 21 • Markus Aarnio
-
Interest Growing In Cancer Stem Cell Biotechs
Mon, May 21 • A John Hodge
-
Galena Biopharma With Near Term ASCO Catalyst
Mon, May 21 • The Swiss Trader
-
Weekly Stock Watch: May 21-25
Mon, May 21 • VFC's Stock House
-
Dendreon: Timing Of News Story Release Is Interesting
Fri, May 18 • Theodore Cohen
-
Dr. Robin Smith Explaining NeoStem: A True Value Play
Fri, May 18 • Brian Nichols
-
Biotech-Focused Baker Bros. $3.7B Fund Bought These 3 Big Winners And Sold Others In Q1
Thu, May 17 • Ganaxi Small Cap Movers
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Dendreon Corporation (DNDN)
Posts on DNDN by Jack Haddad
DNDN has found great support between 20.50 and 21.50.
Exited DNDN and bought to cover June strike 15
DNDN has strong support at 19.
Posts on DNDN by other instabloggers
-
Sat, Mar 24
•
Giancarlo Nicoli
-
Tue, Mar 13
•
Jonathan Spencer
-
Fri, Feb 24
•
Bill Maurer
-
Wed, Feb 8
•
Giancarlo Nicoli
-
Tue, Feb 7
•
Joshua Hayes
All instablog posts on DNDN »Dendreon: Provenge should be given as soon as possible.
Penny Stock Alerts
An Update On 10 Stocks That Could Collapse This Year
Dendreon's Provenge Works. Little Guide To Debunking Inaccurate Info
Stocks Finish Off The Lows As Volume Drops